- LAYER BY LAYER ANATOMICAL INSTRUCTION
- WHERE'S THE NEEDLE
- CLINICAL CONSIDERATIONS
- Describe anatomical changes associated with facial aging, in order to best evaluate the clinical and cosmetic needs of patients.
- Identify the optimal placement of injectable agents, in order to enhance the aesthetic appearance of the face.
- Recognize the anatomical context of critical vascular and neurologic structures within the face, in order to assure patient safety and avoid treatment complications.
This program has been developed for dermatologists, plastic surgeons, ophthalmologists as well as other physicians, nurses and physician assistants who have an interest in gaining and/or increasing their knowledge and technical skill to perform facial aesthetic procedures with injectable agents.
CONFLICT OF INTEREST STATEMENT
The Conflict of Interest Disclosure Policy of Albert Einstein College of Medicine and Montefiore Medical Center requires that faculty participating in any CME activity disclose to the audience any relationship(s) with a pharmaceutical, product or device Company. Any presenter who has disclosed relationships that prove to create a conflict of interest, with regard to their contribution to the activity, will not be permitted to present.
Albert Einstein College of Medicine-Montefiore Medical Center also requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product, or device, not yet approved for use in the United States.
FACULTY AND PLANNING COMMITTEE DISCLOSURES:
Charles M. Boyd, MD, MBA, FACS, has received fees for non-CME/CE services from Allergan, Galderma, Evolus, and Revance Therapeutics, Inc . He has received consulting fees from Allergan and Evolus and speaker fees from Galderma. He has served as a promotional speaker for Galderma and as a member of an advisory board for Allergan, Galderma, and Evolus. He has performed contracted research for Revance Therapeutics, Inc. Dr. Boyd has disclosed that he intends to reference unlabeled/unapproved uses of deoxycholic acid, botulinum toxins, and dermal fillers in his presentation.
Rebecca Fitzgerald, MD, has received fees for non-CME services from Allergan, Galderma, and Merz. She has received consulting fees from Allergan, Galderma, and Merz, and has served as a member of a Speakers’ Bureau for Allergan and Galderma. Dr. Fitzgerald has disclosed that she intends to reference unlabeled/unapproved uses of botulinum toxins and dermal fillers in her presentation.
Timothy M. Greco, MD, FACS,* has received fees for non-CME/CE services from Allergan and Galderma. He has received speaker and consulting fees from Allergan and Galderma, and has served as a promotional speaker for these companies. Dr. Greco has disclosed that he intends to reference unlabeled/unapproved uses of deoxycholic acid, botulinum toxins, and dermal fillers in his presentation.
Steven G. Yoelin, MD, has received fees for non-CME/CE services from Allergan, Merz, Endo, Evolus, Recros Medica, and Sinclair Pharma Ltd. Dr. Yoelin has received consulting fees from Allergan, Endo, Evolus, Recros Medica, and Sinclair Pharma Ltd, and has performed contracted research for Allergan, Merz, Endo, and Recros Medica. He has also served as a promotional speaker for Allergan. Dr. Yoelin has disclosed that he intends to reference unlabeled/unapproved uses of deoxycholic acid, botulinum toxins, and dermal fillers in his presentation.
Victor B. Hatcher, PhD**, has indicated no conflict of interest.
Steve Ruskin, MD*, has indicated no conflict of interest.
**CME Program Reviewer
This CME activity discusses the off-label use of botulinum toxin, hyaluronic acid-based dermal fillers and calcium hydroxylapatite.
AMERICANS WITH DISABILITIES ACT
Albert Einstein College of Medicine-Montefiore Medical Center and the Scientiae, LLC, fully intend to comply with the legal requirements of the Americans with Disabilities Act. If any participant of this activity is in need of special accommodations, please contact PALETTE at least two weeks prior to the activity at 800-401-0291.
This activity is jointly provided by Albert Einstein College of Medicine-Montefiore Medical Center and Scientiae, LLC
Supported by an educational grant and in-kind contribution of disposable and biological supplies from Allergan, Inc. and an educational grant for in-kind contribution of disposable and injectable supplies from DermaSculpt by Cosmofrance.
In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and Scientiae, LLC. Albert Einstein College of Medicine-Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Albert Einstein College of Medicine-Montefiore Medical Center designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
The American Nurses Credentialing Center (ANCC) will accept AMA Category 1 Credits™, on a reciprocal basis, toward their ANCC recertification.
Term of Approval:
April 30, 2018 to December 31, 2020. Original Release Date: April 15, 2013
Method of Participation:
To receive a maximum of 2.0 AMA PRA Category 1 Credit(s)™ you should:
- View all the video modules in this CME activity and evaluate the content presented
- Complete and submit the CME posttest, evaluation form and registration form
To access activity, users will need:
Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher or any other W3C standards compliant browser HTML5 capable browser may be required for video or audio playback.
Statement Regarding Privacy and Security of Learner Records
All learner records (including test scores, attendance, evaluations, case studies, and other identified learning materials) shall be kept private and secure, whether in hardcopy or digital format, using a reasonable standard of diligence. In the event of a breach of learner privacy, learners shall be notified immediately. In addition, every effort shall be made to ensure HIPAA compliance of the personal medical privacy of healthcare patients, and study subjects.